Gastrointestinal Cancers Symposium Media Resource Center.

Embargo Policy

Please note: Due to a technical error, the 2016 Gastrointestinal Cancers Symposium Proceedings was released via the 2016 Cancer Survivorship Symposium Proceedings USB device distributed to meeting attendees. Therefore, we have lifted the embargo on all of the Gastrointestinal Cancers Symposium abstracts.

The embargo on all abstracts part of the 2016 Gastrointestinal Cancers Symposium will lift at 5:00 PM ET on Tuesday, January 19, 2016. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 19 for credentialed media.

Attend the Meeting in Person/Participate in the Presscast

View a recording of the January 19 presscast, featuring three studies from the 2016 Gastrointestinal Cancers Symposium.

ASCO's Media Headquarters is where you can apply for media credentials*, register to attend an upcoming meeting, access embargoed meeting information, and locate presscast dial-in information. For questions about how to navigate the site, please contact mediaregistration@asco.org

*If you attended the 2015 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the presscast. You only have to register if you would like to attend the Symposium in San Francisco.

Media Registration and Housing Instructions

2016 Gastrointestinal Cancers Symposium Media Policies

Access Embargoed Information

Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.

Press Releases

New Regimen for Locally Advanced Rectal Cancer as Effective but Less Toxic Than Chemoradiation
ALEXANDRIA, Va. – Findings from a Polish phase III study point to an additional treatment option for patients with advanced rectal cancer. Read the full release.

New Targeted Hormone-Radiation Treatment Slows Growth of Midgut Neuroendocrine Tumors
ALEXANDRIA, Va. – Early results from a phase III study of patients with previously treated, advanced midgut neuroendocrine tumors show that a novel therapy, 177Lutetium-DOTATATE (Lutathera), may substantially slow tumor growth. Read the full release.

Everolimus Slows Growth of Neuroendocrine Tumors
ALEXANDRIA, Va. – Researchers report the results of a new analysis from a phase III trial of patients with neuroendocrine tumors that begin in the gastrointestinal (GI) tract or have an unknown origin. Read the full release.

2016 Gastrointestinal Cancers Symposium Press Program to Feature New Treatment Strategies, Novel Therapies
ALEXANDRIA, Va. – Co-sponsors of the 2016 Gastrointestinal Cancers Symposium announced today three abstracts that will be highlighted in the meeting’s official Press Program. Read the full release.

View the January 19 Presscast Recording

View a recording of the the January 19 presscast, featuring three studies from the 2016 Gastrointestinal Cancers Symposium.

On-Site Information

Information about the on-site press facilities, including press room location, hours, etc.

Meeting Information

Media Resources

How Can We Help You?

Interview Requests
mediateam@asco.org
Please do not send media registration requests to this email address.

Media Registration Questions
mediaregistration@asco.org

General Questions About the Meeting
Kelly Baldwin, kelly.baldwin@asco.org
Alise Fisher, alise.fisher@asco.org